284 related articles for article (PubMed ID: 9723044)
1. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox.
Glogau RG
Dermatol Surg; 1998 Aug; 24(8):817-9. PubMed ID: 9723044
[TBL] [Abstract][Full Text] [Related]
2. Treatment of axillary hyperhidrosis with botulinum-A toxin.
Salmanpoor R; Rahmanian MJ
Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
[TBL] [Abstract][Full Text] [Related]
3. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
Vergilis-Kalner IJ
J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
[TBL] [Abstract][Full Text] [Related]
4. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis.
Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
J Am Acad Dermatol; 1999 Dec; 41(6):987-90. PubMed ID: 10570385
[TBL] [Abstract][Full Text] [Related]
5. Injectable botulinum toxin as a treatment for plantar hyperhidrosis: a case study.
Vlahovic TC; Dunn SP; Blau JC; Gauthier C
J Am Podiatr Med Assoc; 2008; 98(2):156-9. PubMed ID: 18347128
[TBL] [Abstract][Full Text] [Related]
6. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
Naver H; Swartling C; Aquilonius SM
Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
[TBL] [Abstract][Full Text] [Related]
8. [Liposuction curettage versus Botox for axillary hyperhidrosis. A prospective study of the quality of life].
Ottomann C; Blazek J; Hartmann B; Muehlberger T
Chirurg; 2007 Apr; 78(4):356-61. PubMed ID: 17226006
[TBL] [Abstract][Full Text] [Related]
9. Treatment of focal hyperhidrosis.
Murray CA; Cohen JL; Solish N
J Cutan Med Surg; 2007; 11(2):67-77. PubMed ID: 17374317
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin in the treatment of axillary hyperhidrosis.
Galadari I; Alkaabi J
Skinmed; 2003; 2(4):209-11. PubMed ID: 14673273
[TBL] [Abstract][Full Text] [Related]
11. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin--a possible new treatment for axillary hyperhidrosis.
Bushara KO; Park DM; Jones JC; Schutta HS
Clin Exp Dermatol; 1996 Jul; 21(4):276-8. PubMed ID: 8959898
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin in the treatment of focal hyperhidrosis].
Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
[TBL] [Abstract][Full Text] [Related]
15. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
Odderson IR
Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
[TBL] [Abstract][Full Text] [Related]
16. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval.
Wollina U; Karamfilov T; Konrad H
J Am Acad Dermatol; 2002 Apr; 46(4):536-40. PubMed ID: 11907503
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.
Rompel R; Scholz S
J Eur Acad Dermatol Venereol; 2001 May; 15(3):207-11. PubMed ID: 11683282
[TBL] [Abstract][Full Text] [Related]
18. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
19. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
Karamfilov T; Konrad H; Karte K; Wollina U
Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
[TBL] [Abstract][Full Text] [Related]
20. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
